J. van Meerbeeck (Edegem (Antwerp), Belgium), A. Raniszewska (Warszawa, Poland)
Commuting in Los Angeles: lung cancer health risks of roadway, light-rail and subway transit routes
C. Lovett (Los Angeles, United States of America), F. Shirmohammadi (Los Angeles, United States of America), M. Sowlat (Los Angeles, United States of America), C. Sioutas (Los Angeles, United States of America)
|    |
Genetic susceptibility, residential radon an lung cancer risk in never smokers. Results from the LCRINS Study
M. Lorenzo-González (Santiago de Compostela, Spain), M. Torres-Duran (Vigo, Spain), I. Parente-Lamelas (Ourense, Spain), V. Leiro-Fernandez (Vigo, Spain), J. Abal-Arca (Ourense, Spain), C. Montero-Martínez (A Coruña, Spain), O. Castro-Añon (Lugo, Spain), M. Provencio-Pulla (Madrid, Spain), I. Vidal-García (A Coruña, Spain), A. Golpe-Gomez (Santiago de Compostela, Spain), C. Martinez (Oviedo, Spain), R. Guzman-Taveras (Oviedo, Spain), M. Amenedo-Gancedo (A Coruña, Spain), A. Fernandez-Villar (Vigo, Spain), J. Barros-Dios (Santiago de Compostela, Spain), A. Ruano-Ravina (Santiago de Compostela, Spain)
|  |
Novel non invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles.
Y. Adir (Haifa, Israel), S. Tirman (Haifa, Israel), E. Davidovits (Haifa, Israel), I. Arbel (Haifa, Israel), G. Davidovits (Haifa, Israel), S. Schneer (Haifa, Israel), M. Shteinberg (Haifa, Israel), F. Patolsky (Tel Aviv, Israel)
| |
Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR
A. Koc (Izmir, Turkey), T. Goksel (Izmir, Turkey), B. Komurcuoglu (Izmir, Turkey), O. Ozer Kaya (Izmir, Turkey), B. Ozyilmaz (Izmir, Turkey), P. Gursoy (Izmir, Turkey), Y. Kutbay (Izmir, Turkey), O. Kirbiyik (Izmir, Turkey), T. Ozdemir (Izmir, Turkey), K. Erdogan (Izmir, Turkey), M. Saka Guvenc (Izmir, Turkey), G. Calibasi Kocal (Izmir, Turkey), Y. Baskin (Izmir, Turkey)
| |
The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose®
E. Krauss (Giessen, Germany), J. Zoelitz (Giessen, Germany), J. Wagner (Giessen, Germany), G. Barretto (Bad Nauheim, Germany), M. Degen (Greifenstein, Germany), W. Seeger (Giessen, Germany), A. Guenther (Giessen, Germany)
| |
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
E. Janssens (Antwerp, Belgium), K. Lamote (Antwerp, Belgium), J. Van Meerbeeck (Antwerp, Belgium), L. Brusselmans (Antwerp, Belgium)
| |
Early detection of lung cancer in patients with COPD by eNose technology
R. de Vries (Amsterdam, Netherlands), J. Dagelet (Amsterdam, Netherlands), F. De Jongh (Enschede, Netherlands), J. In 'T Veen (Rotterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), P. Baas (Amsterdam, Netherlands), M. Van Den Heuvel (Nijmegen, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands)
| |
Detecting subtypes of non-small cell lung cancer by electronic nose.
S. Kort (Enschede, Netherlands), M. Tiggeloven (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands), H. Schouwink (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), J. Gerritsen (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands)
| |
Detection of small cell lung cancer by electronic nose.
S. Kort (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands), H. Schouwink (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), J. Gerritsen (Zutphen, Netherlands), J. Van Der Palen (Zutphen, Netherlands)
| |
Simultaneously detected nodules in lung cancers
C. Dogan (Istanbul, Turkey), N. Kiral (Istanbul, Turkey), E. Parmaksiz (Istanbul, Turkey), O. Zengin (Istanbul, Turkey), S. Sagmen (Istanbul, Turkey), A. Fidan (Istanbul, Turkey), S. Comert (Istanbul, Turkey)
| |
Preliminary results of a french pilot trial of lung cancer screening by low dose CT scan in the department of the Somme (DKP80).
O. Leleu (Abbeville, France), E. Hoguet (Abbeville, France), C. Clarot (Abbeville, France), M. Baud (Abbeville, France), E. Barras (Abbeville, France), V. Petigny (Amiens, France), N. Benoit (Amiens, France), M. Auquier (Amiens, France), B. Chauffert (Amiens, France), P. Berna (Amiens, France), V. Jounieaux (Amiens, France)
| |
Chest CT reporting with nodule-tinted spectacles;does it affect nodule/lung cancer services?
N. Paizi (London, United Kingdom), D. Tsakri (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
‘E-Noting Nodulomics’: Automating Electronic Clinical Data Mining and Analysis of Pulmonary Nodules Using a Python Algorithm
R. Lee (London, United Kingdom), R. Morrice (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
Automated Python Algorithm Analysis of Benign Pulmonary Nodules Discharged after 2 years Surveillance
R. Lee (London, United Kingdom), R. Morrice (London, United Kingdom), S. Tran (London, United Kingdom), G. Hardavella (London, United Kingdom)
| |
Recommendation of proper follow-up for peripheral pulmonary lesions with non-malignant result by bronchoscopy
M. Higashiyama (Tokyo, Japan), Y. Matsumoto (Tokyo, Japan), T. Nakai (Tokyo, Japan), M. Tanaka (Tokyo, Japan), T. Tsuchida (Tokyo, Japan)
| |
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
N. Hansen (Odense, Denmark), S. Jeppesen (Odense, Denmark), C. Laursen (Odense, Denmark), E. Jakobsen (Odense, Denmark)
| |